Mesothelioma - 58 Studies Found Recruiting : Vinorelbine in Mesothelioma : Mesothelioma : 2014-05-09 : Drug: Vinorelbine Vinorelbine Completed : Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma : Mesothelioma : 2006-02-22 : Drug: bevacizumab 15 mg/kg IV Completed : Do Your Genes Put You at a Higher Risk of Developing Mesothelioma : Mesothelioma : 2012-04-23 Terminated : An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma : Mesothelioma : 2008-01-09 : Drug: Vinorelbine Other Name: Recruiting : Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma : Mesothelioma : 2013-09-21 Recruiting : A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma : Pleural Mesothelioma : 2016-02-29 : Drug: Pembrolizumab Neoadjuvan Active, not recruiting : Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients : Mesothelioma : 2016-03-09 : Drug: Nivolumab Nivolumab admi Completed : Dendritic Cell-based Immunotherapy in Mesothelioma : Malignant Pleural Mesothelioma : 2006-01-20 : Biological: tumor lysate-loaded autologous dendritic cells 50x10e6 cells per vaccination, 3 times, 2 wee Completed : Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery : Malignant Mesothelioma : 2005-11-11 : Drug: chemotherapy Procedure: adjuvant the Recruiting : PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma : Mesothelioma : 2012-05-21 : Radiation: Prophylactic Irradiation of Tracts (PIT) 21 Gy in 3 fractions <<< Previous | Next >>>